Aprea Therapeutics, Inc. (APRE)
0.7622
0.00 (0.00%)
USD |
NASDAQ |
Mar 20, 16:00
0.7646
0.00 (0.00%)
After-Hours: 20:00
Aprea Therapeutics EPS Diluted (Quarterly) : -0.3194 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Modular Medical, Inc. | -0.1116 |
| Ernexa Therapeutics, Inc. | -0.1923 |
| Recursion Pharmaceuticals, Inc. | -0.2053 |
| Tango Therapeutics, Inc. | -0.2945 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.456M |
| Revenue (Quarterly) | 0.0033M |
| Total Expenses (Quarterly) | 2.459M |
| Enterprise Value | -5.144M |
| Gross Profit Margin (Quarterly) | -63.64% |
| Profit Margin (Quarterly) | -74.41K% |
| Earnings Yield | -259.0% |
| Normalized Earnings Yield | -259.04 |